Australia markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1700-0.0900 (-3.98%)
At close: 04:00PM EDT
2.1300 -0.04 (-1.84%)
After hours: 07:52PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-17,596
-11,122
-27,424
-11,428
-14,414
Depreciation & amortisation
788.495
0.222
788.495
790.972
803.774
Deferred income taxes
-181.752
-
0
-530.611
-1,001
Stock-based compensation
7,172
1,060
8,829
3,408
2,730
Change in working capital
-372.993
605.208
543.604
-1,179
-140.393
Accounts payable
-43.911
-15.931
108.643
-101.789
245.082
Other working capital
-9,835
-8,066
-9,605
-8,717
-3,143
Other non-cash items
354.992
1,392
390.131
384.377
8,878
Net cash provided by operating activities
-9,835
-8,063
-9,605
-8,717
-3,143
Cash flows from investing activities
Investments in property, plant and equipment
-2.776
-2.776
-
-
-
Net cash used for investing activities
0
-2.776
0
-
-
Cash flows from financing activities
Common stock issued
173.987
6,321
0
10,050
17,101
Common stock repurchased
-371.663
0
-388.843
-64.396
-95.212
Other financing activities
-52.746
-52.746
-
-186.493
-95.212
Net cash used provided by (used for) financing activities
-203.884
6,269
-388.843
9,799
17,868
Net change in cash
-10,039
-1,797
-9,994
1,081
14,725
Cash at beginning of period
19,093
6,504
16,498
15,416
691.536
Cash at end of period
9,055
4,706
6,504
16,498
15,416
Free cash flow
Operating cash flow
-9,835
-8,063
-9,605
-8,717
-3,143
Capital expenditure
-2.776
-2.776
-
-
-
Free cash flow
-9,835
-8,066
-9,605
-8,717
-3,143